Details for New Drug Application (NDA): 005970
✉ Email this page to a colleague
NDA 005970 describes SOTRADECOL, which is a drug marketed by Elkins Sinn and Mylan Institutional and is included in two NDAs. It is available from two suppliers. Additional details are available on the SOTRADECOL profile page.
The generic ingredient in SOTRADECOL is sodium tetradecyl sulfate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the sodium tetradecyl sulfate profile page.
The generic ingredient in SOTRADECOL is sodium tetradecyl sulfate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the sodium tetradecyl sulfate profile page.
Summary for 005970
| Tradename: | SOTRADECOL |
| Applicant: | Elkins Sinn |
| Ingredient: | sodium tetradecyl sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 005970
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 005
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
